Literature DB >> 32985227

HIV-positive persons who inject drugs experience poor health outcomes and unmet needs for care services.

Sharoda Dasgupta1, Yunfeng Tie1, Ansley Lemons-Lyn1, Dita Broz1, Kate Buchacz1, R Luke Shouse1.   

Abstract

Comparison of social determinants of health and clinical outcomes between HIV-positive persons who inject drugs (PWID) and HIV-positive persons who do not inject drugs is essential to understanding disparities and informing HIV prevention and care efforts; however, nationally representative estimates are lacking. Interview and medical record data were collected for the Medical Monitoring Project during 2015-2018 among U.S. adults with diagnosed HIV. Among HIV-positive PWID (N=340) and HIV-positive persons who do not inject drugs (N=11,475), we reported weighted percentages and prevalence ratios with predicted marginal means to compare differences between groups (P<.05). Associations with clinical outcomes were adjusted for age, race/ethnicity, and gender. HIV-positive PWID were more likely to be homeless (29.1% vs. 8.1%) and incarcerated (18.3% vs. 4.9%). HIV-positive PWID were less likely to be retained in HIV care (aPR: 0.85 [95% CI: 0.77-0.94]), and were more likely to have poor HIV outcomes, have unmet needs for care services (aPR: 1.50 [1.39-1.61]), seek non-routine care, and experience healthcare discrimination (aPR: 1.42 [1.17-1.73]). Strengthening interventions supporting (1) continuity of care given high levels of incarceration and housing instability, (2) early ART initiation and adherence support, and (3) drug treatment and harm reduction programs to limit transmission risk may improve outcomes among HIV-positive PWID.

Entities:  

Keywords:  Injection drug use; social determinants of health; transmission risk

Mesh:

Substances:

Year:  2020        PMID: 32985227      PMCID: PMC8628508          DOI: 10.1080/09540121.2020.1826396

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  35 in total

1.  Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention.

Authors:  Michael J Mugavero; K Rivet Amico; Andrew O Westfall; Heidi M Crane; Anne Zinski; James H Willig; Julia C Dombrowski; Wynne E Norton; James L Raper; Mari M Kitahata; Michael S Saag
Journal:  J Acquir Immune Defic Syndr       Date:  2012-01-01       Impact factor: 3.731

2.  Durable Viral Suppression and Transmission Risk Potential Among Persons With Diagnosed HIV Infection: United States, 2012-2013.

Authors:  Nicole Crepaz; Tian Tang; Gary Marks; Michael J Mugavero; Lorena Espinoza; H Irene Hall
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

3.  An Exploratory Study to Assess Individual and Structural Level Barriers Associated With Poor Retention and Re-engagement in Care Among Persons Living With HIV/AIDS.

Authors:  Jonathan Colasanti; Natalie Stahl; Eugene W Farber; Carlos Del Rio; Wendy S Armstrong
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

4.  Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors.

Authors:  Amy R Knowlton; Julia H Arnsten; Lois J Eldred; James D Wilkinson; Starley B Shade; Amy S Bohnert; Cui Yang; Lawrence S Wissow; David W Purcell
Journal:  AIDS Patient Care STDS       Date:  2010-07       Impact factor: 5.078

5.  Effectiveness of a Peer Navigation Intervention to Sustain Viral Suppression Among HIV-Positive Men and Transgender Women Released From Jail: The LINK LA Randomized Clinical Trial.

Authors:  William E Cunningham; Robert E Weiss; Terry Nakazono; Mark A Malek; Steve J Shoptaw; Susan L Ettner; Nina T Harawa
Journal:  JAMA Intern Med       Date:  2018-04-01       Impact factor: 21.873

Review 6.  Challenges in managing HIV in people who use drugs.

Authors:  Adeeba Kamarulzaman; Frederick L Altice
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

7.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Leslie Cottle; Xinyi C Zhang; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Sharlaa Faesen; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David D Celentano; Max Essex; Sarah E Hudelson; Andrew D Redd; Thomas R Fleming
Journal:  N Engl J Med       Date:  2016-07-18       Impact factor: 91.245

8.  Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers.

Authors:  Ryan P Westergaard; Bridget K Ambrose; Shruti H Mehta; Gregory D Kirk
Journal:  J Int AIDS Soc       Date:  2012-02-23       Impact factor: 5.396

9.  Knowledge, Beliefs and Practices Regarding Antiretroviral Medications for HIV Prevention: Results from a Survey of Healthcare Providers in New England.

Authors:  Douglas S Krakower; Catherine E Oldenburg; Jennifer A Mitty; Ira B Wilson; Ann E Kurth; Kevin M Maloney; Donna Gallagher; Kenneth H Mayer
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

10.  Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.

Authors:  Nana Wilson; Mbabazi Kariisa; Puja Seth; Herschel Smith; Nicole L Davis
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-03-20       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.